Literature DB >> 31252411

Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease.

Alba Jiménez-Panizo1, Paloma Pérez2, Ana M Rojas3, Pablo Fuentes-Prior4, Eva Estébanez-Perpiñá1.   

Abstract

Nuclear receptors are transcription factors that play critical roles in development, homeostasis and metabolism in all multicellular organisms. An important family of nuclear receptors comprises those members that respond to steroid hormones, and which is subdivided in turn into estrogen receptor (ER) isoforms α and β (NR3A1 and A2, respectively), and a second subfamily of so-called oxosteroid receptors. The latter includes the androgen receptor (AR/NR3C4), the glucocorticoid receptor (GR/NR3C1), the mineralocorticoid receptor (MR/NR3C2) and the progesterone receptor (PR/NR3C3). Here we review recent advances in our understanding of the structure-and-function relationship of steroid nuclear receptors and discuss their implications for the etiology of human diseases. We focus in particular on the role played by AR dysregulation in both prostate cancer (PCa) and androgen insensitivity syndromes (AIS), but also discuss conditions linked to mutations of the GR gene as well as those in a non-steroidal receptor, the thyroid hormone receptor (TR). Finally, we explore how these recent results might be exploited for the development of novel and selective therapeutic strategies.

Entities:  

Keywords:  androgen insensitivity syndromes (AIS); androgen receptor; glucocorticoid receptor; hormone resistance; ligand-binding domain; multimerization; prostate cancer; protein structure

Year:  2019        PMID: 31252411     DOI: 10.1530/ERC-19-0132

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  6 in total

Review 1.  Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

Authors:  Karolien De Bosscher; Sofie J Desmet; Dorien Clarisse; Eva Estébanez-Perpiña; Luc Brunsveld
Journal:  Nat Rev Endocrinol       Date:  2020-04-17       Impact factor: 43.330

Review 2.  Transcriptional Regulation of Energy Metabolism in Cancer Cells.

Authors:  Sara Rodríguez-Enríquez; Álvaro Marín-Hernández; Juan Carlos Gallardo-Pérez; Silvia Cecilia Pacheco-Velázquez; Javier Alejandro Belmont-Díaz; Diana Xochiquetzal Robledo-Cadena; Jorge Luis Vargas-Navarro; Norma Angélica Corona de la Peña; Emma Saavedra; Rafael Moreno-Sánchez
Journal:  Cells       Date:  2019-10-09       Impact factor: 6.600

Review 3.  Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on.

Authors:  Eva Estébanez-Perpiñá; Charlotte L Bevan; Iain J McEwan
Journal:  Cancers (Basel)       Date:  2021-01-29       Impact factor: 6.639

4.  A New Mechanism in THRA Resistance: The First Disease-Associated Variant Leading to an Increased Inhibitory Function of THRA2.

Authors:  Sarah Paisdzior; Ellen Knierim; Gunnar Kleinau; Heike Biebermann; Heiko Krude; Rachel Straussberg; Markus Schuelke
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

5.  Combined FCS and PCH Analysis to Quantify Protein Dimerization in Living Cells.

Authors:  Laura M Nederveen-Schippers; Pragya Pathak; Ineke Keizer-Gunnink; Adrie H Westphal; Peter J M van Haastert; Jan Willem Borst; Arjan Kortholt; Victor Skakun
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

Review 6.  Genome-wide crosstalk between steroid receptors in breast and prostate cancers.

Authors:  Ville Paakinaho; Jorma J Palvimo
Journal:  Endocr Relat Cancer       Date:  2021-07-22       Impact factor: 5.678

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.